Warning letter
Coral Blood Services, Inc.: warning letter of Aug 14, 2002
FDA warning letter UCM145063 · Chicago District Office
Key facts
| Reference number | UCM145063 |
|---|---|
| Company | Coral Blood Services, Inc. |
| Subject | GMP for Blood & Blood Products/Records & Reports/Adulterated |
| Issue date | Aug 14, 2002 |
| Posted date | Aug 14, 2002 |
| Issuing office | Chicago District Office |
| Product type | Biologics |
| CFR sections cited | 606.160(a), 606.160(b), 606.160(e) |
| Country | 3 |
| Inspection city | Chicago |
| Inspection ZIP | 60614-3363 |
| Inspection start date | Jun 19, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: